Cure My Disease

Don't miss your cure!

 Log in / Sign up

Extended trial offers hope for chronic bowel disease patients

NCT ID NCT02531126

Completed Disease control Sponsor: Celgene Source: ClinicalTrials.gov ↗

Summary

This study tested the long-term safety and effectiveness of an oral medication called RPC1063 for people with moderate to severe ulcerative colitis. It involved 877 participants who had already been in previous RPC1063 trials, allowing them to continue treatment for several more years. The main goals were to monitor side effects and see how well the drug maintained control of bowel inflammation and symptoms over time.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Local Institution - 102

    Anaheim, California, 92801, United States

  • Local Institution - 112

    Oak Lawn, Illinois, 60453, United States

  • Local Institution - 117

    Mission Hills, California, 91345, United States

  • Local Institution - 119

    Baton Rouge, Louisiana, 70809, United States

  • Local Institution - 122

    Dallas, Texas, 75246, United States

  • Local Institution - 127

    Jacksonville, North Carolina, 28546, United States

  • Local Institution - 143

    Portland, Oregon, 97239, United States

  • Local Institution - 144

    Tucson, Arizona, 85712, United States

  • Local Institution - 152

    Camperdown, New South Wales, 2050, Australia

  • Local Institution - 179

    Germantown, Tennessee, 38138, United States

  • Local Institution - 236

    London, GREATER LONDON, E11 1NR, United Kingdom

  • Local Institution - 243

    London, SE1 9RT, United Kingdom

  • Local Institution - 264

    Lindsay, Ontario, K9V 5G6, Canada

  • Local Institution - 290

    Oklahoma City, Oklahoma, 73112, United States

  • Local Institution - 337

    Prague, 14021, Czechia

  • Local Institution - 342

    Klatovy, 399 01, Czechia

  • Local Institution - 354

    Wŏnju, 26426, South Korea

  • Local Institution - 364

    Seongnam-si, 13620, South Korea

  • Local Institution - 425

    Kłodzko, 57-300, Poland

  • Local Institution - 450

    Sofia, 1233, Bulgaria

  • Local Institution - 451

    Sofia, 1606, Bulgaria

  • Local Institution - 459

    Sofia, 1336, Bulgaria

  • Local Institution - 505

    Rehovot, 76100, Israel

  • Local Institution - 525

    Berlin, 13353, Germany

  • Local Institution - 535

    Berlin, 12200, Germany

  • Local Institution - 545

    Frankfurt, 60594, Germany

  • Local Institution - 567

    Florence, Tuscany, 50134, Italy

  • Local Institution - 600

    Ghent, 9000, Belgium

  • Local Institution - 601

    Leuven, 3000, Belgium

  • Local Institution - 611

    Osijek, 31000, Croatia

  • Local Institution - 643

    Athens, 10676, Greece

  • Local Institution - 658

    Chisinau, MD-2068, Moldova

  • Local Institution - 659

    Chisinau, MD2025, Moldova

  • Local Institution - 673

    Bucharest, 050098, Romania

  • Local Institution - 677

    Bucharest, 010719, Romania

  • Local Institution - 751

    Vitebsk, 210037, Belarus

  • Local Institution - 808

    Debrecen, 4032, Hungary

  • Local Institution - 816

    Balatonfüred, 8230, Hungary

  • Local Institution - 910

    Bardejov, 08501, Slovakia

  • Local Institution - 954

    Kharkiv, 61039, Ukraine

  • Local Institution - 957

    Vinnytsia, 21018, Ukraine

Conditions

Explore the condition pages connected to this study.

ULCERATIVE COLITIS